#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Systemic candida Mucopolysaccharidosis I Deafness bilateral Primary mediastinal large B-cell lymphoma Warm autoimmune haemolytic anaemia Immune thrombocytopenia Transitional cell cancer of the renal pelvis and ureter Urea cycle disorder Neonatal asphyxia Follicular lymphoma stage I Systemic sclerosis pulmonary Graft versus host disease Precursor T-lymphoblastic lymphoma/leukaemia recurrent Squamous cell carcinoma of the oral cavity Adrenoleukodystrophy More trials…

    Learn about Rare Diseases

    Phenylketonuria – Life with Disease Breast angiosarcoma – Basic Information Adrenogenital syndrome – Diagnostics Osteosarcoma – Diagnostics Primary mediastinal large B-cell lymphoma – Trials in Disease Alagille syndrome Crigler-Najjar syndrome – Basic Information Antisynthetase syndrome – Life with Disease Familial haemophagocytic lymphohistiocytosis – Life with Disease Rhabdomyosarcoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Metformin 2,4 DICHLOROBENZYL ALCOHOL Basimglurant Sotagliflozin Atuliflapon Pf-06480605 IMEROPRUBART Phleum Pratense Pollen Extract Sym023 Mva-209-Fsp-B3 Nilutamide Coffee Charcoal H2-Receptor Antagonist Ulonivirine Cldn6 Car-T(A) Zofenopril Calcium Selgantolimod Mannitol GSKVX000000048110 Opevesostat More therapies…

    Learn about Your Condition

    Toxic epidermal necrolysis Thrombosis prophylaxis External cephalic version Cutaneous T-cell lymphoma Dystonia Infection Eczema Critical illness Orthostatic hypotension Lymphocytic lymphoma Eyelid ptosis Rhabdoid tumour of the kidney Transferrin decreased Behavioural addiction Cardiomyopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of L19TNF and Lomustine for Patients with Recurrent or Progressive Glioblastoma

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Glioma
    Investigated Drugs:
    • Lomustine
    • Onfekafusp Alfa
    Germany Italy

  • Study on the Long-Term Effects of Gadoxetic Acid, Gadoteridol, and Gadobenate Dimeglumine on Motor and Cognitive Functions in Healthy Adults

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Cognitive disorder
    Investigated Drugs:
    • Gadobenate Dimeglumine
    • Gadoteridol
    • Gadoxetic Acid, Disodium
    France Germany Italy

  • Study of Niraparib and Dostarlimab for Patients with Advanced Non-Small Cell Lung Cancer or Malignant Pleural Mesothelioma with Specific Genetic Mutations

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Pleural mesothelioma
    • Non-small cell lung cancer
    Investigated Drugs:
    • Niraparib
    • Dostarlimab
    Italy

  • Study on the Safety of Dasatinib and Quercetin for Patients with Mild Cognitive Impairment or Early Alzheimer’s Disease

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Quercetin
    • Dasatinib
    Spain

  • Study on the Effects of PPV-06 and Paracetamol for Patients with Inflammatory Knee Osteoarthritis

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • His203-Crm197
    • Paracetamol
    Czechia Denmark France Poland Romania

  • Study on Doravirine and Raltegravir for Maintaining Viral Control in HIV Patients with Low Viral Load

    Not yet recruiting

    1 1 1 1
    Investigated Drugs:
    • Doravirine
    • Raltegravir
    France Italy Spain
Previous Page
1 … 844 845 846 847 848 … 1,673
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!